Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -737.04% is in line with its 1-year average of -673.90%, around the middle of its 1-year range (-1134.21%–0.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1134.21%.
OPERATING MARGIN
-737.04%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Generate Biomedicines, Inc.
Market Cap
$1.75B
Operating Margin
-737.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.73B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.78B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.71B
Operating Margin
1.20%
TTM Avg
-1.69%
3Y Avg
-4.84%
5Y Avg
-5.86%
Market Cap
$1.84B
Operating Margin
29.46%
TTM Avg
25.49%
3Y Avg
21.64%
5Y Avg
22.06%
Market Cap
$1.66B
Operating Margin
-134.48%
TTM Avg
-159.75%
3Y Avg
-419.83%
5Y Avg
-335.87%
Market Cap
$1.85B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
Market Cap
$1.86B
Operating Margin
-873.87%
TTM Avg
-1020.17%
3Y Avg
-1557.98%
5Y Avg
-1038.65%
Market Cap
$1.66B
Operating Margin
-5.55%
TTM Avg
-16.51%
3Y Avg
-27.71%
5Y Avg
-34.02%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.75B | -737.04% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 11.69% | -8.16% | -10.59% | -4.68% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -651.67% | -787.38% | -968.58% | -820.03% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.71B | 1.20% | -1.69% | -4.84% | -5.86% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.84B | 29.46% | 25.49% | 21.64% | 22.06% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | -134.48% | -159.75% | -419.83% | -335.87% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 2.61% | 3.43% | 5.52% | 6.07% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.86B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | -5.55% | -16.51% | -27.71% | -34.02% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 15.35% | 4.65% | 1.95% | -3.05% |
Gross Margin
100.0%
Operating Margin
-737.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1134.21% |
| 2026-03-31 | -887.49% |
| 2025-12-31 | 0.00% |
